Skip to main content
. 2020 Apr 20;12:94. doi: 10.1007/s40820-020-00429-x

Fig. 3.

Fig. 3

The in vitro therapeutic efficacy evaluated by CCK-8 assay (*p < 0.05, **p < 0.01, and ***p < 0.001; n = 4 per group) (a), live/dead assay (b), Scale bar: 200 μm, and Annexin V-FITC/PI apoptosis assay (c)